Back

Norepinephrine transporter inhibition prevents tilt-induced vasovagal syncope: a randomized, placebo controlled trial

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Syncope Drug Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Satish R Raj

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)

10 More presentations in this session

Presentation thumbnail
Risk predictors of supraventricular tachycardia and bradycardia necessitating therapy in patients with unexplained syncope receiving implantable loop recorder.
Doctor T. Onuki (Yokohama, JP)
Abstract
Presentation thumbnail
Etiology of syncope in patients with severe aortic stenosis
Doctor J. Francisco Pascual (Barcelona, ES)
Abstract Slides
Presentation thumbnail
High incidence of injury due to vasovagal and bradyarrhythmic syncope
Doctor P. Pournazari (Calgary, CA)
Abstract Slides
Presentation thumbnail
Sex-specific symptoms in the early diagnosis of syncope
Doctor J. Du Fay De Lavallaz (Basel, CH)
Abstract
Presentation thumbnail
Diagnostic concordance after long-term follow-up of patients evaluated in a syncope unit
Ms P. Guardia Martinez (Malaga, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Syncope

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
How to manage patients with bradycardic phenotype: pace or ablate or...?
thumbnail
Congress Session
A practical update on diagnosis and treatment of vasovagal syncope
thumbnail
Congress Presentation
Young patient with syncopes and seizures: Antiepileptic drugs, pacemaker or cardioneuroablation?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources